Together we are beating cancer

Donate now

Neuroblastoma

Showing 12 out of 22 results
A Cancer Research UK-funded researcher in the lab.

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

by Tim Gunn | News | 10 January 2024

10 January 2024

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments. Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

by Cancer Research UK | Research Feature | 3 September 2021

3 September 2021

T cell

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma. A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

by Emma Smith | Analysis | 3 May 2017

3 May 2017

Our scientists have discovered that neuroblastoma cells can produce a cellular ‘kryptonite’ that seems to sap the power from nearby immune cells. Our scientists have discovered that neuroblastoma cells can produce a cellular ‘kryptonite’ that seems to sap the power from nearby immune cells.

by Alan Worsley | Analysis | 1 August 2015

1 August 2015

Scientist looking at petri dish
  • Science & Technology
  • Health & Medicine

Childhood cancer cells drain immune system’s batteries

Cancer cells in neuroblastoma release a molecule that breaks down a key energy source for the body’s immune cells, leaving them too drained to fight the disease Cancer cells in neuroblastoma release a molecule that breaks down a key energy source for the body’s immune cells, leaving them too drained to fight the disease

by Cancer Research UK | News | 1 August 2015

1 August 2015

Manchester youngster Harley Renshaw has had his courage recognised with a special award as he fights cancer in his kidney, neck, lung and bones. Manchester youngster Harley Renshaw has had his courage recognised with a special award as he fights cancer in his kidney, neck, lung and bones.

by Cancer Research UK | News | 3 December 2014

3 December 2014

Neuroblastoma is a type of childhood cancer and our researchers are pioneering new clinical trials to tackle aggressive forms of the disease - how does it work? Neuroblastoma is a type of childhood cancer and our researchers are pioneering new clinical trials to tackle aggressive forms of the disease - how does it work?

by Emma Smith | Analysis | 13 August 2013

13 August 2013

Cancer Research UK scientists and paediatric cancer specialists have launched the BEACON-neuroblastoma trial, which aims to find the best chemotherapy regimen for children and young adults with recurring or resistant neuroblastoma. Researchers will also investigate whether blocking the growth of new blood vessels supplying the tumours can enhance this treatment. Cancer Research UK scientists and paediatric cancer specialists have launched the BEACON-neuroblastoma trial, which aims to find the best chemotherapy regimen for children and young adults with recurring or resistant neuroblastoma. Researchers will also investigate whether blocking the growth of new blood vessels supplying the tumours can enhance this treatment.

by Cancer Research UK | News | 13 August 2013

13 August 2013